Showing results (71-80 of 154) with videos related to

Sort By:
Pageof 16
Archives of Disease in Childhood|October 8, 2014
Paediatric cerebral sinovenous thrombosis: findings of the International Paediatric Stroke StudyR N Ichord, S L Benedict, A K Chan, et al.
European Journal of Pediatrics|January 29, 2000
The course of fibrinolytic proteins in children with malignant bone tumoursU Nowak-Göttl, N Münchow, U Klippel, et al.
Transplantation|September 10, 1999
Heterozygous prothrombin gene mutation: a new risk factor for early renal allograft thrombosisJ Oh, F Schaefer, A Veldmann, et al.
The Journal of Pediatrics|November 1, 1996
Thromboembolism and resistance to activated protein C in children with underlying cardiac diseaseB Kohlhase, H Vielhaber, H G Kehl, et al.
Acta Diabetologica|May 12, 2025
A 14-year prospective cohort study of type 2 diabetes development in Dutch healthy adults of South Asian origin: risk factors and the association with metabolic syndrome and HOMA-IRSebastian B Beckmann, Priyanti Bhawan, Tobias Bruning, et al.
British Journal of Haematology|December 21, 2000
Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors - a multicentre case-control study. For the Childhood Thrombophilia Study GroupC Heller, R Schobess, K Kurnik, et al.
Klinische Padiatrie|November 1, 1991
15 parameters of coagulation and fibrinolysis in children with type I diabetes mellitus (onset period)M Koert, U Nowak-Göttl, W Kreuz, et al.
European Journal of Pediatrics|January 29, 2000
Multicentre evaluation of combined prothrombotic defects associated with thrombophilia in childhood. Childhood Thrombophilia Study GroupS Ehrenforth, R Junker, H G Koch, et al.
Thrombosis Research|July 18, 2001
Interaction of fibrinolysis and prothrombotic risk factors in neonates, infants and children with and without thromboembolism and underlying cardiac disease. a prospective studyU Nowak-Göttl, S Kotthoff, E Hagemeyer, et al.
Haematologica|September 1, 1995
Inefficacy of fresh frozen plasma in the treatment of L-asparaginase-induced coagulation factor deficiencies during ALL induction therapyU Nowak-Göttl, B Rath, M Binder, et al.
Pageof 16